Researchers have revealed new details about the CRISPR-Cas5-HNH/Cascade complex, a variant of the type I-E CRISPR-Cas system, ...
News Medical on MSN12h
Using CRISPR to remove extra chromosomes in Down syndromeGene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...
No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...
A study published in Nature Communications and conducted by researchers from the Institute of Physics of the Chinese Academy of Sciences revealed new ...
CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) will likely be announcing its earnings results before the market opens on ...
USDA Animal and Plant Health Inspection Service (APHIS) announced on January 23, 2025, that it is reinstating its legacy ...
Applied DNA Sciences Inc (APDN) reports increased revenues and strategic shifts, while addressing financial hurdles and ...
Most mutations that decreased antibiotic susceptibility were related to specific metabolic pathways. A MIC-increase to ...
The global Gene Editing Market was valued at $5.1 billion in 2022 and is projected to reach $16.2 billion by 2030, growing at ...
CRISPR Therapeutics (NASDAQ:CRSP – Free Report) had its price objective cut by The Goldman Sachs Group from $66.00 to $57.00 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback